Circassia Pharmaceuticals said it would terminate the development and commercialisation agreement with AstraZeneca for the US commercial rights to Tudorza and Duaklir as the company...
Clinical stage biotherapeutics company PureTech Health has reported a strong capital base with $321.5m in pro-forma cash in its annual results to 31 December 2019...
Frontier IP, a specialist in commercialising intellectual property, said its portfolio company Alusid has launched a new luxury brand called Block through a Kickstarter campaign...
Online rail and coach ticketing platform Trainline has announced its chief executive will take a 50% salary reduction for the 'foreseeable future' and that it...